BioSpace News Archive

BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration

The fitness and health product innovator launches a new platform to increase clinician access to precise data, creating a more streamlined and efficient experience with manual muscle testing

As marijuana becomes mainstream and usage rates skyrocket, some of the nation’s top cancer doctors are urging the Surgeon General to investigate the link between smoking marijuana and lung cancer.

The Newest Lab Within the Good Housekeeping Institute Will Test and Identify Products that Prioritize Safety and Efficacy to Advance the Health and Wellness Industry

Funding Part of Leading Duchenne Organization’s Cardiac Initiative

Windgap Medical, Inc. announced that it has finalized a deal to enable a strategic investment from Molex Ventures, LLC, a subsidiary of Koch Industries.

While there are a variety of feminine hygiene products for use during menstrual periods, they are not always effective in keeping clothing clean

Ultivue, a developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced two new additions to its existing UltiMapper platform of multiplex fluorescence immunohistochemistry research kits

Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial focus on developing novel therapies for the treatment of Dry Eye Disease, today announced that Jeffrey Nau, M.M.S., Ph.D., President and CEO, is scheduled to present a corporate overview at the BIO CEO & Investor Conference on Tuesday, February 12th, 2019 at 10:30 a.m. EST in New York.

A leading Texas orthopedic surgeon, Dr. Alain Elbaz of Advanced Orthopedics & Sports Medicine, is helping to introduce Houston to a state-of-the art, FDA-cleared technology that utilizes a patient’s own natural adipose—body fat—to promote healing to injured and damaged areas